Drug Type Biological products |
Synonyms QUC 398, QUC-398 |
Target |
Mechanism ADAMTS5 inhibitors(ADAMTS5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 2 | US | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | AU | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | DK | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | FR | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | ES | 09 Nov 2022 |